Loading...

Eurofins-Cerep SA

ALECR.PAEURONEXT
Healthcare
Medical - Diagnostics & Research
17800.00
0.00(0.00%)

Eurofins-Cerep SA ALECR.PA Peers

See (ALECR.PA) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Diagnostics & Research Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
ALECR.PA€17,800.00+0.00%89.8M12.55€1,418.66N/A
BIM.PA€125.60+2.95%14.8B34.51€3.64+0.72%
ERF.PA€65.90+4.01%11.6B29.03€2.27+0.91%
LBIRD.PA€18.45+0.27%406.1M70.96€0.26N/A
MDXH.BR€3.02-3.76%85.6M-1.58-€1.91N/A
BCART.BR€0.29+0.00%27.2M-0.32-€0.92N/A
ALBIO.PA€1.24+0.40%22.6M-0.37-€3.33N/A
ALPRE.PA€3.54+7.27%13.3M-2.97-€1.19N/A
EEP.MC€0.54N/A6.3M-54.00-€0.01N/A
MLAHC.PA€0.60+0.00%5.4M-10.00-€0.06N/A
Showing 1 to 10 of 11 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

ALECR.PA vs BIM.PA Comparison

ALECR.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALECR.PA stands at 89.8M. In comparison, BIM.PA has a market cap of 14.8B. Regarding current trading prices, ALECR.PA is priced at €17,800.00, while BIM.PA trades at €125.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALECR.PA currently has a P/E ratio of 12.55, whereas BIM.PA's P/E ratio is 34.51. In terms of profitability, ALECR.PA's ROE is +0.10%, compared to BIM.PA's ROE of +0.11%. Regarding short-term risk, ALECR.PA is less volatile compared to BIM.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALECR.PA.

Stock Price Comparison

Loading...

Frequently Asked Questions

;